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Abstract
Background: Previous studies from the USA have shown that acute nuclear myocardial perfusion
imaging (MPI) in low risk emergency department (ED) patients with suspected acute coronary
syndrome (ACS) can be of clinical value. The aim of this study was to evaluate the utility and
hospital economics of acute MPI in Swedish ED patients with suspected ACS.
Methods: We included 40 patients (mean age 55 ± 2 years, 50% women) who were admitted from
the ED at Lund University Hospital for chest pain suspicious of ACS, and who had a normal or non-
ischemic ECG and no previous myocardial infarction. All patients underwent MPI from the ED, and
the results were analyzed only after patient discharge. The current diagnostic practice of admitting
the included patients for observation and further evaluation was compared to a theoretical "MPI
strategy", where patients with a normal MPI test would have been discharged home from the ED.
Results: Twenty-seven patients had normal MPI results, and none of them had ACS. MPI thus had
a negative predictive value for ACS of 100%. With the MPI strategy, 2/3 of the patients would thus
have been discharged from the ED, resulting in a reduction of total hospital cost by some 270 EUR
and of bed occupancy by 0.8 days per investigated patient.
Conclusion: Our findings in a Swedish ED support the results of larger American trials that acute
MPI has the potential to safely reduce the number of admissions and decrease overall costs for low-
risk ED patients with suspected ACS.
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Background
It has been estimated that some 180000 patients with
chest pain suspicious of ACS (= acute myocardial infarc-
tion, AMI, or unstable angina pectoris) present at Swedish
emergency departments (EDs) each year [1,2]. Current
diagnostic methods for ACS in the ED, however, are
clearly suboptimal. As a result, "rule-out" admissions are
very common, and 7 out of 10 patients admitted for sus-
pected ACS prove not to have it [1,3]. Also, many cases of
ACS are diagnosed only after lengthy observation, with a
resulting delay in therapy and an impaired prognosis. As
many as 2–5% of those with ACS are erroneously sent
home from the ED [4,5].
To overcome these problems, several new diagnostic
methods have been suggested [6], e.g. echocardiography
[7], multidetector CT scanning [8] and nuclear myocardial
perfusion imaging (MPI) [9]. Acute MPI has been shown
to be of value in routine care in the USA [10,11], primarily
because of a high negative predictive value for ACS in
patients with ongoing or recently abated chest pain and a
non-diagnostic ECG. MPI may thus accurately identify
patients who can be safely discharged directly from the
ED. US studies also show that acute MPI can be cost effec-
tive[12]. To our knowledge however, no European study
has yet evaluated the economy of acute MPI.
In the present study, the aim was to evaluate the utility
and hospital economics of acute MPI in Swedish ED
patients with suspected ACS.
Methods
Institution and patient material
Lund University Hospital (USiL) is a 1200 bed institution
with fully public financing that serves a population of
some 250 000, and has some 65 000 ED visits per year.
Percutaneous coronary intervention (PCI) and coronary
bypass surgery (CABG) are available 24 hours/day.
After informed consent, we prospectively included a con-
venience sample of 40 patients with chest pain suspicious
of ACS attending the ED at USiL from 2002 to 2006. Dur-
ing the inclusion period, there was no systematic diagnos-
tic protocol for patients with suspected ACS, no dedicated
chest pain unit, and no formal strategy for admitting ED
patients to in-hospital care. However, most admitted
patients underwent serial blood testing and ECGs, as well
as a pre-discharge exercise ECG when necessary. As far as
known, no significant change in the usual care took place
over the inclusion period. Inclusion and exclusion criteria
are shown in figure 1.
Discharge diagnoses were made by the responsible physi-
cian according to European Society of Cardiology/Ameri-
can College of cardiology consensus documents using
Troponin T as the critical biomarker [13], with a cut-off at
0.05 μg/L. In the study, diagnoses were noted "as is" from
the patient records, and no further review was made. For
patients with normal MPI results, the computerized
patient records at USiL were used to identify ischemic car-
diac events at 6 months after the index visit. Patients lack-
ing notes of cardiac events at 6 months were interviewed
by telephone to identify such events.
In January 2008, 1 EUR equalled 9.36 SEK. Unless stated
otherwise, results are given as mean ± SEM.
Myocardial scintigraphy
All patients underwent acute MPI after intravenous
administration of a body-weight adjusted dose (7.5 MBq/
kg) of 99mTc-tetrofosmin (MyoviewTM, GE Health care
Life Sciences, Stockholm, Sweden) administered immedi-
ately after inclusion at the ED by personnel from the Divi-
sion of Clinical Physiology. Electrocardiogram-gated
(eight frames) single-photon emission computed tomog-
raphy (SPECT) images were obtained in the supine posi-
tion with a dual-head gamma camera (Vertex, ADAC
Laboratories, Milpitas, CA, USA) according to a standard-
ised clinical protocol. In short the acquisition was per-
formed approximately 60–120 minutes after tracer
injection, using a dual-head gamma camera with high-res-
olution, parallel-hole collimators. Data were collected at
32 projections over a 180 degree orbit, 40 seconds per
projection, and 64 × 64 matrix zoomed to a pixel size of 5
mm. Attenuation correction was not used. SPECT images
were reconstructed and post-filtered (Butterworth order,
5.0; cut-off fre quency, 0.6). The SPECT reconstruction
and reorientation were automatically performed using
Autospect plus (ADAC Laboratories), however, an experi-
enced operator manually made corrections, if needed. The
images were analysed in AutoQuant 4.3.1 (ADAC Labora-
tories). The images were interpreted by two physicians in
consensus after patients were discharged from hospital
and blinded to all clinical data and the discharge diagno-
sis. In this clinical setting a high sensitivity is required.
Therefore, perfusion images had to be homogenous with
no perfusion defects or attenuation artifacts, and EF and
LV volumes had to be normal, in order for the scan to be
read as normal.
Economy
The hospital-related costs for each patient including all
diagnostic procedures were retrieved from USiL's compu-
terized economy system (PKS). All costs were the actual
costs at the time of patient inclusion. The total cost of care
and diagnostic work-up for each patient, excluding the
cost for the study MPI, was considered to represent the
cost of the current diagnostic practice. The cost of this
approach was then compared to the cost of a theoretical
management strategy where the same patient's MPI resultBMC Emergency Medicine 2009, 9:12 http://www.biomedcentral.com/1471-227X/9/12
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was accessible to the ED physician and where the patient
would have been discharged home from the ED directly
after a non-pathological MPI result. For this theoretical
strategy ("MPI strategy") the cost was postulated to be the
total cost, including the cost of MPI, minus the cost of all
in-hospital care and diagnostic tests performed after the
ED. Length of stay and diagnosis at discharge were
retrieved from USiL's computerized patient records sys-
tems (Melior, Siemens/PASIS, TietoEnator).
Since income data for the included patients were unavail-
able, the average cost of loss of societal production due to
hospitalization was based on data on the mean salary for
persons in Southern Sweden from the Swedish Central
Bureau of Statistics, reflecting the expected background of
the included patients. One day of lost production was
assumed for patients admitted less than 24 hours. No cost
for loss of production was calculated for patients over 65
years, as they were presumed to be retired.
Ethical approval
The Research Ethics Committee at Lund University
approved the study.
Results
MPI results and discharge diagnoses
The included 40 patients were on average 55 ± 2 years
(35–80). Patients' characteristics are shown in Table 1.
Twenty-five patients had ongoing chest pain at presenta-
tion and the remaining patients were without symptoms
for an average of 1.1 hour. Twenty-seven patients had nor-
mal MPI results and none of these had ACS (Table 2). Sen-
sitivity was thus 100% (2/2; 95% CI 16 – 100%) as was
the negative predictive value (NPV). Specificity was 71%
(27/38; 95% CI 54 – 85%) and the positive predictive
Inclusion/exclusion criteria and diagnostic protocol Figure 1
Inclusion/exclusion criteria and diagnostic protocol.BMC Emergency Medicine 2009, 9:12 http://www.biomedcentral.com/1471-227X/9/12
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value (PPV) was 15% (2/13). The false positive MPI
results were found to be due to breast attenuation in five
cases, inferior attenuation in three cases, inadequate qual-
ity of imaging in one case and two cases were classified as
positive due to decreased left ventricular function only.
Discharge diagnoses and length of stay for all 40 patients
are shown in Table 3. The average length of hospital stay,
for all patients and for patients with normal MPI, was 1.3
± 0.2 days vs. 1.2 ± 0.2 days, respectively. At 6 months
after the index visit, one of the 27 patients with normal
MPI had been diagnosed with pericarditis (at one month),
and none with ACS. A diagnostic strategy using acute MPI
would thus potentially allow the immediate discharge of
67% (27/40) of the patients from the ED.
Economics of the current diagnostic practice versus an 
MPI strategy
Diagnostic tests and related costs for all 40 patients are
presented in Table 4. Length of stay accounted for 71% of
the total admission cost with the current diagnostic prac-
tice. Table 5 shows total hospital costs for the current diag-
nostic practice and the MPI strategy. As can be seen, the
MPI strategy would potentially reduce costs by 267 ± 96
EUR and bed occupancy by 0.8 ± 0.16 days per patient
undergoing MPI.
Excluding patients >65 years, there were a total of 18
potentially saved work days (144 h), corresponding to a
reduction in production loss of 69 EUR per patient under-
going MPI.
Discussion
Our results suggest that acute MPI in selected low risk ED
patients with suspected ACS can safely reduce hospital
admissions by some 2/3. Such a reduction would result in
a saving of about 0.8 bed days and 270 EUR per patient
investigated with MPI.
Our findings support previous results from larger North
American trials that acute MPI can reduce costs and admit-
tance to in-hospital care in low or moderate risk patients
with suspected ACS, with preserved diagnostic safety. In a
large multi-center randomized trial, Udelson et al[10]
found that in patients with chest pain and a non-ischemic
ECG, MPI reduced unnecessary hospitalizations by 20%.
In a smaller randomized study [14] with similar patients,
an acute MPI strategy significantly reduced the median
length of hospitalization by 2 days and the overall median
cost by 49%.
Although the conclusions from our study should be lim-
ited due to the small sample size, our results indicate that
these North American findings are also valid in a Scandi-
navian setting. In previous small European trials [15,16],
MPI was found to have a negative predictive value for ACS
of 96%. These results are however difficult to compare
with ours, since a delay of up to six hours after symptom
presentation to isotope injection was allowed. Other stud-
ies [9] have shown that the sensitivity and negative predic-
tive value declines with injections later than 2 hours after
symptoms.
So far only two studies [16,17] have analyzed MPI per-
formance with the newer AMI definition using troponin
as a biomarker, as in the present investigation. In one of
the studies [17], the sensitivity of acute MPI was only 75%
when performed in patients with a moderate (instead of
low) ACS risk, which in spite of an openly negative MPI
still were admitted for serial biomarker sampling. Due to
the unacceptable low sensitivity the authors concluded
that MPI as a diagnostic tool was suboptimal in patients
with a moderate risk of ACS. It thus seems as acute MPI
should only be used to reduce "unnecessary" admissions
in low risk ACS patients, and that the individual chest
pain patient should be thoroughly risk-stratified before
deciding the diagnostic method.
Because of the ability to select patients for ED discharge,
MPI has been jointly recommended by the American Col-
lege of Cardiology/American Heart Association/American
Society of Nuclear Cardiology [18] in low risk ED patients
Table 1: Patient characteristics
Number (%)
Men 20 (50)
Diabetes 2 (5)
Current smoker 11 (27)
Hypertension 9 (22)
Family history of ischemic heart disease 22 (55)
History of angina pectoris 10 (25)
History of CABG or PCI 2 (5)
Hypercholesterolemia 4 (10)
Congestive heart failure 0 (0)
History of stroke 3 (8)
Non-ischemic ECG changes 10 (25)
Table 2: MPI results and ACS outcome
MPI result Total
Normal Pathologic
Discharge diagnosis
No ACS 27 11 38
ACS 0 2 2
Total 27 13 40BMC Emergency Medicine 2009, 9:12 http://www.biomedcentral.com/1471-227X/9/12
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with suspected ACS and a non-ischemic ECG. An addi-
tional advantage with MPI is that it is well suited for tele-
medicine applications, reducing the need for on-site
physicians for MPI interpretation. Since the perfusion is
imaged, there is also a potential for earlier detection of
ACS, but published positive predictive values are low
[10,19]. In the present study, the PPV was only 15%,
which indicates that the clinical value of MPI for this pur-
pose is very limited.
The benefits of introducing MPI of course depend on the
local standard of care. In the present study, the average 1.3
days of hospital stay could have been reduced by 0.8 days
with the MPI strategy. In comparison, a mean length of
stay of 3.8 days in another study [14] was cut to 1.4 days
when MPI results were available to the ED physicians,
with no change in patient outcome.
Disadvantages with MPI include that the test itself is
expensive, and that it exposes the patient to radiation, in
our case approximately 3 mSv. In the present study, per-
sonnel from the department of Clinical Physiology
brought the isotope to the ED and injected it into the
patient. If this is not practical, implementation of MPI in
routine care will likely require training of ED personnel,
adoption of guidelines for handling isotopes, and perhaps
even rebuilding rooms for radiation safety. MPI would
probably not be suitable for centers where nuclear cardi-
ology experts are not present or where the patient volume
is small. With an annual attendance at our ED of some
65000 patients, we predict that there will be one or two
patients per 24 h suitable for acute MPI. Due to the rela-
tively high cost of the MPI itself, it seems important to
ascertain that only patients who would otherwise be
admitted to in-hospital care are referred to MPI. If not, as
with any new diagnostic test, there is a risk of overuse
which would decrease the potential cost savings. Another
risk is that false positive MPI results induce unnecessary
and expensive further testing, which will also reduce cost
savings. When implementing MPI in routine care, it seems
essential to inform the physicians about the very low PPV
in these patients.
Several other new diagnostic methods have been sug-
gested to be of value in the chest pain patient with sus-
pected ACS [6]. Coronary angiography using
multidetector CT scanning (MDCT) has shown promising
results and in a meta-analysis by Vanhoenacker et al. the
pooled sensitivity and specificity were 95% and 90% [20]
in detecting non-ST-elevation ACS. MDCT has the advan-
tage over MPI to be a very rapid investigation and to be
available in more centers and more often outside office
hours. MDCT also has the potential to detect other causes
Table 3: Discharge diagnoses and length of stay for all patients
Number of patients (number of patients with normal MPI)
Days in hospital
Discharge diagnosis <1 1 2 3 4 5
Chest pain, unspecified 11 (7) 16 (12) - 1 (1) 1 (1) -
Supraventricular tachycardia (e.g atrial fibrillation) - 3 (3) ----
G a s t r o e s o p h a g e a l  r e f l u x 1  ( 0 ) 1  ( 1 )----
M y a l g i a - 2  ( 1 )----
Stable angina pectoris - 1 (1) 1 (0) - - -
Acute subendocardial infarction - - - - 1 (0) 1 (0)
Number of patients 12 (7) 23 (18) 1 (0) 1 (1) 2 (1) 1 (0)
Table 4: Diagnostic tests after the ED and related costs for all 
patients
Cost (EUR)
Length of stay (n = 40) 745 ± 81
Diagnostic tests
Blood samples 24 ± 3
Exercise-ECG (n = 15) 118 ± 1
X-ray (n = 12) 98 ± 37
Coronary angiography (n = 3) 730 ± 166
Echocardiography (n = 3) 120 ± 6
Myocardial Perfusion Imaging 283 ± 8
Total in-ward cost (n = 40) 895 ± 120
ED cost (excl. MPI) n = 40 344 ± 10
Table 5: Costs and potential reduction of costs with MPI 
strategy
Pr Patient
EUR
Cost according to diagnostic strategy
Current diagnostic approach 1239 ± 119
MPI strategy 973 ± 118
Consequences of using MPI strategy
Reduction of costs 266 ± 96
Reduction of days in hospital 0.8 ± 0.16 DaysBMC Emergency Medicine 2009, 9:12 http://www.biomedcentral.com/1471-227X/9/12
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of chest pain than acute cardiac disease. A disadvantage
with MDCT is that it exposes the patient to a larger radia-
tion dose (5–20 mSv) than rest MPI.
Extending MPI availability outside office hours would
most likely increase the cost per MPI investigation. The
exact cost increase will of course be different at every
center, but a larger patient volume than ours would prob-
ably be needed to make an on-call physician and standby
isotope economically feasible. In our hospital, about one
patient a day during office hours can be acutely imaged
within the existing capacity of the MPI-cameras.
Limitations
Our study only included a small fraction of the potentially
eligible subjects during the study period, which in theory
could lead to a selection bias. There were however no sys-
tematic criteria for patient selection other than the inclu-
sion criteria described in Methods, and the included
patients were therefore considered to be a random sample
of all eligible patients. The patients included in this study
were on average eight years younger than our chest pain
patients in general [21]. This probably reflects our exclu-
sion criteria (e.g. normal ECG and no previous AMI) but
could of course also be caused by a general tendency to
include younger patients, which would then in turn lead
to an overestimation of the working days saved using the
MPI strategy. The prevalence of ACS was low in our study,
and this could theoretically reflect a selection of patients
with a particularly low risk of ACS, actually suitable for ED
discharge without an MPI. However, our ACS prevalence
was comparable to that in previous studies [10,19], and
the hospital admission of our patients was decided before
inclusion in the study. Changes in the cost of care of
course occurred during the inclusion period, but these
changes were small. If anything, the cost changes would
cause us to underestimate the cost reduction with a future
MPI implementation. There was no review of the patients'
discharge diagnoses. On the other hand, the follow-up
revealed that none of the patients with normal MPI results
had had an ACS at 6 months.
This study only evaluated MPI as a means to identify
patients suitable for discharge home from the ED, i.e. to
exclude ACS. Underlying coronary artery disease could
still exist in the patients with a negative MPI, at least in the
12 patients who were not evaluated with exercise ECGs or
coronary angiography during the 6 month follow up
period. We consider it unlikely however, since in these
cases the attending physician did not consider further
investigations necessary to exclude coronary artery dis-
ease.
Conclusion
For ED patients with suspected ACS, a normal or non-
ischemic ECG and no previous AMI, this study confirms
that acute MPI has the potential to safely reduce admis-
sions to in-hospital care as well as costs. This would allow
limited health care resources to be focused on patients
with true ACS, where rapid intervention clearly improves
the prognosis.
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